Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate SI-BONE, Inc. before investing.

In this article, we go over a few key elements for understanding SI-BONE, Inc.’s stock price such as:

• SI-BONE, Inc.’s current stock price and volume
• Why SI-BONE, Inc.’s stock price changed recently
• Upgrades and downgrades for SIBN from analysts
• SIBN’s stock price momentum as measured by its relative strength

About SI-BONE, Inc. (SIBN)

Before we jump into SI-BONE, Inc.’s stock price, history, target price and what caused it to recently , let’s take a look at some background.

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Want to learn more about SI-BONE, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about SI-BONE, Inc..

SI-BONE, Inc.’s Stock Price as of Market Close

As of June 18, 2026, 4:00 PM, CST, SI-BONE, Inc.’s stock price was $15.840.

SI-BONE, Inc. is 0% from its previous closing price of $15.840.

During the last market session, SI-BONE, Inc.’s stock traded between $15.325 and $15.950. Currently, there are approximately 43.96 million shares outstanding for SI-BONE, Inc..

SI-BONE, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

SI-BONE, Inc. Stock Price History

SI-BONE, Inc.’s (SIBN) price is currently up 12.34% so far this month.

During the month of June, SI-BONE, Inc.’s stock price has reached a high of $16.000 and a low of $13.412.

Over the last year, SI-BONE, Inc. has hit prices as high as $21.890 and as low as $11.480. Year to date, SI-BONE, Inc.’s stock is down 19.68%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused SI-BONE, Inc. Stock’s Price to ?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of June 18, 2026,, no analysts have changed their rating of SI-BONE, Inc.’s stock over the last month.

Additionally, you'll want to evaluate SI-BONE, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on SI-BONE, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

SI-BONE, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about SI-BONE, Inc. (SIBN) by visiting AAII Stock Evaluator.

Relative Price Strength of SI-BONE, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 18, 2026, SI-BONE, Inc. has a weighted four-quarter relative price strength of -1.88%, which translates to a Momentum Score of 53 and is considered to be Average.

Want to learn more about how SI-BONE, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

SI-BONE, Inc. Stock Price: Bottom Line

As of June 18, 2026, SI-BONE, Inc.’s stock price is $15.840, which is 0% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like SI-BONE, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.